Apeloa Pharmaceutical Co.,Ltd (SHE:000739)
China flag China · Delayed Price · Currency is CNY
18.81
+0.02 (0.11%)
Apr 28, 2026, 3:05 PM CST

SHE:000739 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
3,6353,7863,6623,5813,5532,610
Trading Asset Securities
----0.0914.89
Cash & Short-Term Investments
3,6353,7863,6623,5813,5532,625
Cash Growth
4.89%3.41%2.26%0.78%35.35%13.61%
Accounts Receivable
2,5802,2712,2652,2432,0401,523
Other Receivables
12.2499.96112.26114.46116.28103.74
Receivables
2,5922,3712,3782,4212,1561,626
Inventory
1,3891,6021,8602,0831,8021,250
Prepaid Expenses
-7.334.6426.6520.5913.06
Other Current Assets
276.45112.57282.71256.96249.5267.72
Total Current Assets
7,8927,8798,1878,3687,7815,782
Property, Plant & Equipment
3,4723,5833,7753,5643,4062,588
Long-Term Investments
191.23186.68139.66174.0591.4181.25
Goodwill
20.3120.3120.3120.3120.3120.31
Other Intangible Assets
298.12300.74314.61319.8338.93346.05
Long-Term Deferred Tax Assets
230.06234.7227.66247.4270.2947.58
Long-Term Deferred Charges
87.183.5715.7720.5766.2146.76
Other Long-Term Assets
58.7925.445.8353.7547.15133.22
Total Assets
12,25012,31812,72912,76812,0219,045
Accounts Payable
3,2623,3823,6334,1274,3112,623
Accrued Expenses
100.52258.26251.62226.43202.82221.62
Short-Term Debt
1,0801,027814.03807.8562.81332.47
Current Portion of Long-Term Debt
-1581.340.40.2
Current Portion of Leases
-5.366.617.988.6513.77
Current Income Taxes Payable
123.03121.1792.3377.0480.59120.56
Current Unearned Revenue
181.05185.89514.33430.37458.26302.4
Other Current Liabilities
336.34384.67425.26550.05402.44165.8
Total Current Liabilities
5,0835,3655,7436,3086,0273,779
Long-Term Debt
459.26468.370.0518.71249.62104.94
Long-Term Leases
16.1318.9113.784.4715.8122.95
Long-Term Unearned Revenue
59.2951.8531.6930.6215.121.17
Long-Term Deferred Tax Liabilities
63.5867.784.98103.71122.964.25
Other Long-Term Liabilities
--36727272
Total Liabilities
5,6815,9725,9796,5376,5023,985
Common Stock
1,1581,1581,1691,1791,1791,179
Additional Paid-In Capital
104.79104.79247438.01438.01438.01
Retained Earnings
5,8075,5585,4814,8044,0963,443
Treasury Stock
-509.98-482.06-153.09-200.2-200.2-
Comprehensive Income & Other
0.54-0.96-2.022.01-0.790.43
Total Common Equity
6,5616,3386,7426,2235,5125,060
Minority Interest
8.187.927.927.697.35-
Shareholders' Equity
6,5696,3466,7506,2305,5195,060
Total Liabilities & Equity
12,25012,31812,72912,76812,0219,045
Total Debt
1,5551,520909.47920.3837.3474.33
Net Cash (Debt)
2,0802,2662,7522,6602,7162,151
Net Cash Growth
-23.05%-17.66%3.45%-2.04%26.27%8.61%
Net Cash Per Share
1.811.962.372.282.311.82
Filing Date Shares Outstanding
1,1261,1261,1581,1691,1691,179
Total Common Shares Outstanding
1,1261,1281,1581,1691,1691,179
Working Capital
2,8092,5142,4442,0601,7552,003
Book Value Per Share
5.835.625.825.324.714.29
Tangible Book Value
6,2436,0176,4075,8835,1534,694
Tangible Book Value Per Share
5.545.345.535.034.413.98
Buildings
-2,0321,9911,7431,7431,474
Machinery
-5,1624,7674,3984,1262,903
Construction In Progress
-244.11407.48545.85311.4710.22
Source: S&P Global Market Intelligence. Standard template. Financial Sources.